Class information for:
Level 1: ANIPAMIL//KINGS CARDIOVASC BIOL MED//ISCHEMIA AND RE PERFUSION

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
15182 726 35.9 45%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
8 4 CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL 1276458
11 3       ATRIAL FIBRILLATION//CARDIAC & CARDIOVASCULAR SYSTEM//CATHETER ABLATION 130936
377 2             JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY//PHOSPHOLAMBAN//CARDIAC & CARDIOVASCULAR SYSTEM 17144
15182 1                   ANIPAMIL//KINGS CARDIOVASC BIOL MED//ISCHEMIA AND RE PERFUSION 726

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 ANIPAMIL authKW 257606 1% 88% 7
2 KINGS CARDIOVASC BIOL MED address 134585 1% 80% 4
3 ISCHEMIA AND RE PERFUSION authKW 84117 0% 100% 2
4 LAMBETH CONVENTIONS authKW 84117 0% 100% 2
5 PHASE 2 ARRHYTHMIAS authKW 84117 0% 100% 2
6 PROFIBRILLATORY EFFECT authKW 84117 0% 100% 2
7 CARDIOL EXPTL CARDIOL address 75703 0% 60% 3
8 ISCHEMIC ARRHYTHMIAS authKW 65709 1% 31% 5
9 IC ANTIARRHYTHMIC DRUGS authKW 56076 0% 67% 2
10 ISCHEMIC VENTRICULAR FIBRILLATION authKW 56076 0% 67% 2

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Cardiac & Cardiovascular System 11656 50% 0% 360
2 Pharmacology & Pharmacy 3225 40% 0% 287
3 Peripheral Vascular Diseases 582 9% 0% 65
4 Physiology 320 8% 0% 59
5 Cell Biology 43 6% 0% 44
6 Hematology 37 3% 0% 22
7 Medicine, Research & Experimental 17 3% 0% 22
8 Anesthesiology 8 1% 0% 7
9 Toxicology 7 2% 0% 13
10 Engineering, Biomedical 3 1% 0% 8

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 KINGS CARDIOVASC BIOL MED 134585 1% 80% 4
2 CARDIOL EXPTL CARDIOL 75703 0% 60% 3
3 AG EXPT KARDIOL 42058 0% 100% 1
4 BIOL PHARMACOL GRP 42058 0% 100% 1
5 CARDIOPULM RS UNIT 42058 0% 100% 1
6 CARDIOVASC IRG 42058 0% 100% 1
7 CARDIOVASC S PHARMACOL GRP 42058 0% 100% 1
8 ENVIRONM MED CIRCULAT P 42058 0% 100% 1
9 GLOBAL SAFETY PHARMACOLPRECLIN DEV SAFETY 42058 0% 100% 1
10 INTERUNIV CARDIOL INTERNAL MED 42058 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 CARDIOVASCULAR RESEARCH 11858 6% 1% 47
2 JOURNAL OF CARDIOVASCULAR PHARMACOLOGY 11537 8% 1% 55
3 JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY 10339 6% 1% 40
4 BRITISH JOURNAL OF PHARMACOLOGY 6878 7% 0% 54
5 JOURNAL DE PHARMACOLOGIE 6138 1% 2% 7
6 EUROPEAN JOURNAL OF CARDIOLOGY 5109 0% 4% 3
7 AMERICAN HEART JOURNAL 3562 5% 0% 35
8 JOURNAL OF PHARMACOLOGICAL METHODS 3462 1% 1% 8
9 CARDIOVASCULAR DRUGS AND THERAPY 2610 2% 1% 11
10 JAPANESE HEART JOURNAL 2385 2% 1% 11

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 ANIPAMIL 257606 1% 88% 7 Search ANIPAMIL Search ANIPAMIL
2 ISCHEMIA AND RE PERFUSION 84117 0% 100% 2 Search ISCHEMIA+AND+RE+PERFUSION Search ISCHEMIA+AND+RE+PERFUSION
3 LAMBETH CONVENTIONS 84117 0% 100% 2 Search LAMBETH+CONVENTIONS Search LAMBETH+CONVENTIONS
4 PHASE 2 ARRHYTHMIAS 84117 0% 100% 2 Search PHASE+2+ARRHYTHMIAS Search PHASE+2+ARRHYTHMIAS
5 PROFIBRILLATORY EFFECT 84117 0% 100% 2 Search PROFIBRILLATORY+EFFECT Search PROFIBRILLATORY+EFFECT
6 ISCHEMIC ARRHYTHMIAS 65709 1% 31% 5 Search ISCHEMIC+ARRHYTHMIAS Search ISCHEMIC+ARRHYTHMIAS
7 IC ANTIARRHYTHMIC DRUGS 56076 0% 67% 2 Search IC+ANTIARRHYTHMIC+DRUGS Search IC+ANTIARRHYTHMIC+DRUGS
8 ISCHEMIC VENTRICULAR FIBRILLATION 56076 0% 67% 2 Search ISCHEMIC+VENTRICULAR+FIBRILLATION Search ISCHEMIC+VENTRICULAR+FIBRILLATION
9 TRANSITORY MYOCARDIAL ISCHEMIA 56076 0% 67% 2 Search TRANSITORY+MYOCARDIAL+ISCHEMIA Search TRANSITORY+MYOCARDIAL+ISCHEMIA
10 CLASS I ANTIARRHYTHMICS 54072 0% 43% 3 Search CLASS+I+ANTIARRHYTHMICS Search CLASS+I+ANTIARRHYTHMICS

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 PUGSLEY, MK , RIES, CR , GUPPY, LJ , HARVIE, CJ , WALKER, MJA , (1995) EFFECTS OF ANIPAMIL, A LONG-ACTING ANALOG OF VERAPAMIL, IN PIGS SUBJECTED TO MYOCARDIAL-ISCHEMIA.LIFE SCIENCES. VOL. 57. ISSUE 12. P. 1219-1231 20 100% 6
2 CURTIS, MJ , MACLEOD, BA , WALKER, MJA , (1987) MODELS FOR THE STUDY OF ARRHYTHMIAS IN MYOCARDIAL-ISCHEMIA AND INFARCTION - THE USE OF THE RAT.JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY. VOL. 19. ISSUE 4. P. 399 -419 42 47% 124
3 CLEMENTS-JEWERY, H , HEARSE, DJ , CURTIS, MJ , (2005) PHASE 2 VENTRICULAR ARRHYTHMIAS IN ACUTE MYOCARDIAL INFARCTION: A NEGLECTED TARGET FOR THERAPEUTIC ANTIARRHYTHMIC DRUG DEVELOPMENT AND FOR SAFETY PHARMACOLOGY EVALUATION.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 145. ISSUE 5. P. 551-564 32 30% 34
4 CLEMENTS-JEWERY, H , ANDRAG, E , HEARSE, DJ , CURTIS, MJ , (2009) COMPLEX ADRENERGIC AND INFLAMMATORY MECHANISMS CONTRIBUTE TO PHASE 2 VENTRICULAR ARRHYTHMIAS IN ANAESTHETIZED RATS.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 156. ISSUE 3. P. 444 -453 17 49% 5
5 MURASATO, Y , NAGAMOTO, Y , URABE, T , KURAOKA, F , NAKASHIMA, Y , KUROIWA, A , (1997) EFFECTS OF LIDOCAINE AND DILTIAZEM ON RECOVERY OF ELECTROPHYSIOLOGIC ACTIVITY DURING PARTIAL REPERFUSION FOLLOWING SEVERE MYOCARDIAL ISCHEMIA IN CANINE HEARTS.JOURNAL OF ELECTROCARDIOLOGY. VOL. 30. ISSUE 2. P. 113-125 18 67% 0
6 FARKAS, A , CURTIS, MJ , (2002) LIMITED ANTIFIBRILLATORY EFFECTIVENESS OF CLINICALLY RELEVANT CONCENTRATIONS OF CLASS I ANTIARRHYTHMICS IN ISOLATED PERFUSED RAT HEARTS.JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. VOL. 39. ISSUE 3. P. 412 -424 21 46% 11
7 AUPETIT, JF , FRASSATI, D , BUI-XUAN, B , FREYSZ, M , FAUCON, G , TIMOUR, Q , (1998) EFFICACY OF A BETA-ADRENERGIC RECEPTOR ANTAGONIST, PROPRANOLOL, IN PREVENTING ISCHAEMIC VENTRICULAR FIBRILLATION: DEPENDENCE ON HEART RATE AND ISCHAEMIA DURATION.CARDIOVASCULAR RESEARCH. VOL. 37. ISSUE 3. P. 646 -655 16 64% 22
8 CURTIS, MJ , (1991) THE RABBIT DUAL CORONARY PERFUSION MODEL - A NEW METHOD FOR ASSESSING THE PATHOLOGICAL RELEVANCE OF INDIVIDUAL PRODUCTS OF THE ISCHEMIC MILIEU - ROLE OF POTASSIUM IN ARRHYTHMOGENESIS.CARDIOVASCULAR RESEARCH. VOL. 25. ISSUE 12. P. 1010-1022 21 64% 28
9 WALKER, MJA , CURTIS, MJ , HEARSE, DJ , CAMPBELL, RWF , JANSE, MJ , YELLON, DM , COBBE, SM , COKER, SJ , HARNESS, JB , HARRON, DWG , ET AL (1988) THE LAMBETH CONVENTIONS - GUIDELINES FOR THE STUDY OF ARRHYTHMIAS IN ISCHEMIA, INFARCTION, AND REPERFUSION.CARDIOVASCULAR RESEARCH. VOL. 22. ISSUE 7. P. 447-455 13 59% 840
10 CORONEL, R , (1994) HETEROGENEITY IN EXTRACELLULAR POTASSIUM CONCENTRATION DURING EARLY MYOCARDIAL-ISCHEMIA AND REPERFUSION - IMPLICATIONS FOR ARRHYTHMOGENESIS.CARDIOVASCULAR RESEARCH. VOL. 28. ISSUE 6. P. 770-777 25 44% 51

Classes with closest relation at Level 1


Rank Class id link
1 30435 CICLETANINE//5 AMINOLAEVULIC ACID//CA2 AND MG2 CONTENTS
2 7174 R 56865//DELAYED AFTERDEPOLARIZATION//DIASTOLIC DEPOLARIZATION
3 26415 PRIMARY VENTRICULAR FIBRILLATION//ACSIS REGISTRY//ACUTE LIPEMIA
4 18845 UPTAKE1//CARDIAC PHYSIOL//NON EXOCYTOTIC RELEASE
5 7162 SOTALOL//DOFETILIDE//CLASS III ANTIARRHYTHMIC AGENT
6 11943 WB4101//POSITIVE INOTROPIC EFFECT//ALPHA1 ADRENERGIC RECEPTOR SUBTYPES
7 1683 REPERFUSION//REPERFUSION INJURY//OXYGEN FREE RADICALS
8 31516 SALVICINE//DIPFLUZINE//DIPFLUZINE HYDROCHLORIDE
9 12867 GLYCEROL OUTPUT//PALMITOYLCARNITINE//OXFENICINE
10 22882 BEPRIDIL//CAS 117241 46 0//REVUE DE MEDECINE

Go to start page